VAX-014

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameVAX-014
Drug Alias NameVAX-014
ClassificationBiologicsNatural product/Extract > Microbial extract
Mechanisms of ActionCell death stimulantsIntegrin alpha 3/beta 1 modulatorsIntegrin alpha-5/beta-1 antagonists
TargetsIntegrin alpha 3/beta 1Integrin alpha-5/beta-1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxiion Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesVaxiion Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A